BCYC
Bicycle Therapeutics plc
NASDAQ · Healthcare · Biotechnology · GB
$4.30
+1.42%Margins
Gross margin
100.0%
EBITDA margin
-299.3%
EBIT margin
-343.7%
Net margin
-311.1%
FCF margin
-335.9%
-37.3%
Return on equity
-31.4%
Return on assets
-40.1%
Return on invested capital
0.10x
Asset turnover
-$205.7M
Cash from operations
$7.29
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026